AdvaMed Praises House and Senate for Passage of Medical Device User Fee Reauthorization

In separate statements issued over the past few weeks, the president and CEO of the Advanced Medical Technology Association commended the House and the Senate for passing legislation to reauthorize the Medical Device User Fee Act.

 

Speaking about MDUFA, Stephen J. Ubl of AdvaMed said, in the House-related release, "This potentially game-changing user fee agreement includes provisions that will strengthen accountability measures provide additional FDA resources. And under the agreement, the FDA is presented with an opportunity to improve its predictability, consistency and efficiency, while continuing to adhere to its high standard for product approval."

 

With the two versions of the legislation now passed, Mr. Ubl spoke of AdvaMed's desire to assist Congress in reconciling them so the agreement is passed "promptly."

 

Related Articles on AdvaMed:

AdvaMed Commends Congress on Progress on Reauthorization of Medical Device User Fees

AdvaMed Unveils Three-Year Strategic Policy and Advocacy Plan

AdvaMed Study: Change to Medical Technology Industry's Operating Environment Would Hurt Jobs, R&D, Innovation

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers